MEDLINE MAXORB EXTRA ALGINATE WOUND DRESSING 4X4 SQUARE REF MSC7044EP MEDLINE MOXORB EXTRA ALBIN...
FDA Device Recall #Z-0619-2025 — Class II — October 1, 2024
Recall Summary
| Recall Number | Z-0619-2025 |
| Classification | Class II — Moderate risk |
| Date Initiated | October 1, 2024 |
| Status | Ongoing |
| Voluntary | Voluntary: Firm initiated |
Recalling Firm
| Firm | Advanced Medical Solutions Ltd. |
| Location | Winsford |
| Product Type | Devices |
| Quantity | 1,800 boxes |
Product Description
MEDLINE MAXORB EXTRA ALGINATE WOUND DRESSING 4X4 SQUARE REF MSC7044EP MEDLINE MOXORB EXTRA ALBINATE WOUND DRESSING 4X8 RECTANLE REF MSC7048EP Wound dressing indicated for moderate to heavily exuding chronic and acute wounds, and to control minor bleeding in superficial wounds.
Reason for Recall
Due to defects on primary packaging pouch that compromise the device's ability to maintain a sterile barrier.
Distribution Pattern
U.S. Nationwide distribution in the states of IL, TX, and VA.
Lot / Code Information
Model Number: MSC7044EP UDI-DI code: 10080196296842 Lot Number: W00070789 Model Number: MSC7048EP UDI-DI code: 10080196296828 Lot Number: W00070988
Other Recalls from Advanced Medical Solutions Ltd.
| Recall # | Classification | Product | Date |
|---|---|---|---|
| Z-0617-2025 | Class II | Hollister CalciCare Calcium Alginate Dressing R... | Oct 1, 2024 |
| Z-0618-2025 | Class II | McKesson Calcium Alginate Dressing MFR# 3562 ... | Oct 1, 2024 |
| Z-2719-2016 | Class II | ReliaMed¿ Silver Alginate/CMC. Each dressing is... | Jan 15, 2015 |
| Z-2720-2016 | Class II | ReliaMed¿ Alginate/CMC. Each dressing is packe... | Jan 15, 2015 |
Frequently Asked Questions
Sterility recalls for medical devices vary in severity. If you have already had a procedure using a potentially non-sterile device, contact your healthcare provider immediately — you may need monitoring for signs of infection. Symptoms to watch for include fever, redness or swelling at the surgical site, unusual pain, or discharge. For devices that have not yet been used, they should be quarantined and returned to the manufacturer per the recall notice. Non-sterile implants can cause serious infections; early detection and treatment are critical.
Class I recalls indicate a reasonable probability of serious adverse health consequences or death from the defect. Class II recalls involve products that may cause temporary or medically reversible adverse health consequences, or where serious consequences are remote. Class III recalls cover products not likely to cause any adverse health consequences, typically involving technical regulatory violations. The classification guides urgency — Class I recalls require immediate action, while Class III may simply involve returning a product or acknowledging a labeling change. Always read the specific recall notice for recommended patient actions.
Report problems with medical devices to the FDA through MedWatch at 1-800-FDA-1088 or online at FDA.gov/safety/medwatch. Healthcare facilities are required by law to report device-related serious injuries and deaths. Patients and consumers can also report voluntarily. Include the device name, manufacturer, model number, and a description of the problem and any patient outcome. Reports from patients and clinicians help the FDA identify emerging safety signals and may trigger investigations that lead to recalls of dangerous devices.
What Should You Do?
Stop using this device if you are affected by this recall. Contact your healthcare provider and the manufacturer immediately for guidance. Report adverse events to FDA MedWatch.